The Path Ahead for M&A

The Questions

Bayer AG’s proposed $66 billion takeover of Monsanto would create, by far, the industry giant capturing more than a quarter of the world’s seed and agchem market.

“The reason for the mergers is not driven by any one company’s need to carry out their internal strategy as much as it is about shareholders demanding continued growth and improved earnings per share.” --Garrett Stoerger, Verdant Partners
“The reason for the mergers is not driven by any one company’s need to carry out their internal strategy as much as it is about shareholders demanding continued growth and improved earnings per share.” –Garrett Stoerger, Verdant Partners

Based on size alone, “it’s hard for people to be dismissive of it,” says Garrett Stoerger, Partner at M&A advisory and consulting firm Verdant Partners. If it does go through, and it appears chances are good as overlap of the two businesses is limited to a few select crops, there are other questions — such as how to unify two disparate company cultures.

Dr. Werner Antweiler, Associate Professor at the University of British Columbia’s Sauder School of Business, recalled one very famous mega-merger of American and German companies from back in 1998, and the culture-clashing chaos that ensued. “Will this deal realize its full potential, or will it go the way of Daimler-Chrysler and flounder?”

“It’s far from clear to me the two cultures will be able to merge into a new approach that satisfies both sides. Without strong leadership from Bayer, they are at risk of repeating the same mistakes,” Antweiler tells AgriBusiness Global.

“Moreover, the Monsanto brand is more liability than asset, while the rich Monsanto R&D pipeline and patents, and Monsanto’s expertise on the agritech-IT (‘smart farming’) side are the most promising gains for Bayer.”

Commenting on the broader agchem backdrop of late, “There is a lot of skepticism; so many things are going on at the same time,” Rob Dongoski, Partner, Global Agribusiness Leader with Ernst & Young, says.

He’s right: The year felt like one long merger announcement, one of the last (at least for 2016, but we could be wrong) being the Agrium-Potash tie-up.

And then the U.S. election further confounded things.

According to analysts we spoke with, it’s anyone’s guess whether a Trump presidency will prove friendlier to the mergers or move in the direction of slowing down foreign takeovers. While there is an element of uncertainty, it’s clear that the new administration’s focus will be on corporate tax and trade policy.

“We are waiting with baited breath to see how aggressive (Trump’s) policy initiatives will be as respects global trade and preservation of U.S. jobs,” says Kenneth S. Zuckerberg, Executive Director, Senior Research Analyst with Rabobank’s Food & Agribusiness Research and Advisory group.

Desirable Assets
It’s no secret that appeasing antitrust watchdogs will entail asset divestitures. All told, $12.8 billion worth of assets at minimum could hit the market because of consolidation, according to estimates by analyst Christian Faitz with Kepler Cheuvreux.

As Bayer CEO Liam Condon told the German daily Die Tageszeitung in late November, “In North America the combined market share in cotton is indeed quite high. We anticipate that parts of this business may have to be divested.” U.S. government data shows Monsanto and Bayer had about 70% of U.S. cottonseed sales last year.

He added, “Another strong market position in North America will emerge in canola.”



The genetics developed by Bayer and Monsanto command about 70% of the market for that crop in Canada, Stoerger says. Vegetable seeds, due to the high number of species and specialized markets, is a less obvious area that could need attention, he adds, as market share is substantial between Monsanto’s Seminis, the world’s largest vegetable seed company, and Bayer’s Nunhems.

The big question focuses on the agrichemicals piece of the pie. Will Bayer keep the Liberty/LibertyLink glufosinate business, or will Monsanto retain its original claim to fame, Roundup Ready?

Dongoski says it’s a toss-up on which scenario plays out, but the sheer expansiveness of the Roundup business — worth about $4.8 billion in annual sales — may give it the edge on staying put.

The omnipresent weedkiller clearly has its issues, including the risk it won’t be reauthorized in Europe when the AI’s 18-month extension there runs out at the end of 2017. On the flip side, Monsanto has finally secured EPA approval for its “replacement” Xtend dicamba-based technology for soy and cotton.

Yet, one could argue convincingly the upper hand lies with LibertyLink, a choice alternative for growers desperate for ways to control glyphosate-resistant weeds.

With more than 60 million acres of corn, cotton, soybeans, and canola now having the LibertyLink trait, Bayer expects acreage to double across multiple crops in the next few years. It also previously unveiled a $500 million investment to double worldwide production of Liberty, beginning in mid-2017.

The Other Deals

For DuPont, it has revealed it will sell a business making herbicides pending its merger with Dow AgroSciences, according to a Bloomberg report. It also said DuPont is considering disposing of insecticide and seeds units that might pose an obstacle to the deal.

“We can expect that DuPont will divest one of its older herbicide portfolios, rather than letting go of one of its newer herbicide brands like its newly announced FeXapan brand,” Laura Lee of research firm Lux Research wrote in a November report. Lee named Breakfree and Cinch herbicides as brands it may potentially divest, some formulations of which contain active ingredients atrazine, acetochlor, and S-metolachlor.

“The changing regulatory attitudes surrounding atrazine may push DuPont toward divesting this specific technology, especially while the company is under pressure to trim its herbicide business,” Lee noted.

However, less restrictive geographies are still prime regions to accept the technology, she said, noting that the Canadian Pest Management Regulatory Agency proposed for the continuation of atrazine and trifluralin registrations last December. In addition, Australia recently approved the registration of an atrazine-based herbicide.

Of the three deals, Syngenta-ChemChina should be the easiest to get past regulators, as the combination with the Chinese company’s Adama would still only result in 19% market share, according to a Bloomberg report citing a research note by Citigroup analyst Andrew Benson. Some disposals of fungicides and herbicides may be required, Benson said.

The most logical buyers of assets up for grabs resulting from the trio of mega-mergers, say analysts, will be other agchem players, but expect private equity firms, such as Paine & Partners and PPG, as well as second-tier seed companies and big U.S. ag retailers feeling the pinch of input suppliers to join the mix of (highly) interested parties.

“Do large fertilizer players combine with the new agchem giants to bring everything to farm? That’s a potential.” --Rob Dongoski, Ernst & Young
“Do large fertilizer players combine with the new agchem giants to bring everything to farm? That’s a potential.” –Rob Dongoski, Ernst & Young

“Farm sizes are getting bigger, and there is a more direct relationship with suppliers. (Ag retailers) are feeling threatened by that,” Dongoski says.

BASF’s Markus Heldt commented in a press briefing that the company will “actively seek to exploit the opportunities arising from the ongoing mergers in order to strengthen our presence and expand our offer.” Syngenta CFO John Ramsay also told dealReporter in July that it is ready to buy assets divested in the Bayer-Monsanto merger, including cotton and vegetable seeds.

Unintended Effects

The knee-jerk reaction to consolidation is that product choice and innovation will suffer. There is a natural fear that a high concentration of market share will be a negative for farmers, Zuckerberg says.

“If you step back and look at what usually goes on (with M&A activity), new competitors, spin-offs, and innovators often come to the table.” He points out that entire new classes of inputs emerging on the market — microbials, biostimulants, and seed treatments — originated from smaller, niche companies, which were later picked up, developed, and brought to market by the multinationals.

While Zuckerberg believes marginal products will go away, he argues that combining R&D dollars “will probably result in positive product innovation after the mergers become integrated. From an innovation standpoint, it is possible there could actually be more product choices, rather than fewer.” It’s a counterintuitive view shared by many experts.

Aside from the chief goals of growing market share and spurring innovation, the mergers also have the potential to reshape relationships between end users and suppliers, as new technologies and digitization shake up traditional business models to shift toward more shared risk.

“How the combinations will manifest in on-farm value has the potential to go way beyond chemistry and seed. It has the potential to shift risk and create visibility across the entire value chain,” Dongoski says. “Changing that relationship could enable emerging markets and smallholders to leapfrog into areas they haven’t gotten into previously.”

In the shorter term, smaller-scale companies will also be poised to take advantage of their larger competitors who are distracted by the demanding integration process.

“The reason for the mergers,” Stoerger explains, “is not driven by any one company’s need to carry out their internal strategy as much as it is about shareholders demanding continued growth and improved earnings per share. An unintended consequence is that this is going to consume tremendous resources and time by all companies involved.”

All of this, and it could be that the M&A wave is just beginning.

“Do I think this is the end of transactions? Not even close,” Stoerger adds. “This will set off a secondary wave of carve-outs, spin-offs, and divestitures of assets deemed anti-competitive or no longer strategic to the newly combined businesses.”

According to Ernst & Young’s annual survey of U.S. executives, the Capital Confidence Barometer, three-quarters of ag respondents reported they will be actively pursuing acquisitions in the next 12 months. “I think it’s true to what is going to happen,” Dongoski says. “No doubt that based on the survey result and our conversations in the market, companies in ag are looking for growth.”

He also points out that growers’ largest expenditure has not been brought into the agchem circle yet: fertilizer. “Do large fertilizer players combine with the new agchem giants to bring everything to farm? That’s a potential.”

Topics: ,

Leave a Reply



As Agchem Complexity Grows, Specialists Take Off Some of the Heat

Chemical companies increasingly are using specialist suppliers to outsource the process development and production of complex new molecules.

Africa/Middle East

Bayer Closes Monsanto Acquisition

Bayer successfully completed the acquisition of Monsanto on Thursday. Shares in the U.S. company will no longer be traded on

Flag of China

Nearly 30,000 Companies Fined in Chinese Environmental Inspections

According to CCM, fines totaled $224.60 million. Over 18,000 individuals were fined.

day 2 trade summit

PFMAI’s Dave: Indian Bill Is ‘Total Surrender’ to Multinationals

New legislation falls short and gives unfair advantage to importers and multinationals, Indian manufacturers say.

Africa/Middle East

Bayer Plans Closing of Monsanto Acquisition on June 7

Bayer plans to complete the acquisition of Monsanto on June 7, following the receipt of all required approvals from regulatory


Two HELM Agro Herbicides Approved in California

HELMET and HELMET SPC are HELM Agro US’ newest additions to the metolachlor herbicide portfolio.


U.S. Imports of Formulated Crop Protection Products

As a barometer of global crop protection product prices and demand, U.S.-based Fanwood Chemical analyzes U.S. formulated product import data.


China Plant Shutdowns Hurt Helm Results

The company said its Crop Protection business was faced with markets exhibiting weak growth momentum overall in 2017.


Monsanto Enters Collaboration to Fight Asian Soybean Rust

2Blades will deliver resistance genes in further collaboration with The Sainsbury Laboratory and the Universidade Federal de Viçosa.


FMC Names Mark Douglas President, Chief Operating Officer

FMC Corp. announced several changes to its executive leadership, effective June 1, 2018.


China Reports Significant Resistance Issues

China's National Agricultural Technology Extension Service Center (NATESC) reported that the main pests and diseases in food crops have developed significant resistance to the most commonly used pesticides.


Bayer: Disappointing Verdict Requires In-Depth Analysis

Bayer will assess the verdict’s consequences and potential legal options.


EU Court Backs Ban on Three Neonicotinoids

General Court of the European Union said it "confirms the validity of the restrictions introduced at EU level in 2013 clothianidin, thiamethoxam and imidacloprid because of the risks those substances pose to bees."


Formulation Technology Matters with High-Activity Sulfonylurea Herbicides

Herbicide formulations and sprayer clean-out are top of mind for many farmers, applicators, and retailers because of issues with dicamba


Tight Supply of Chinese Glycine Pushes Up Glyphosate Prices

China's announcement that it will conduct further pollution inspections in 2018 and 2019 is constraining the supply of glycine, the main intermediate for glyphosate production, according to market intelligence firm CCM.


Bayer Unveils Executive Leadership Team for Crop Science

Liam Condon will lead division; Brett Begemann will become Head of Commercial Operations (Chief Operating Officer).


Monsanto Execs to Step Down After Bayer Deal Closes

Monsanto Co. Chairman and Chief Executive Officer Hugh Grant announced his intent to leave Monsanto at the closing of the acquisition of Monsanto by Bayer AG.


FMC Quarterly Results Soar on DuPont Acquisition

FMC Corp. reported its Agricultural Solutions business posted first-quarter 2018 revenue of $1.1 billion, an increase of 109 percent year-over-year.


Bayer Crop Science Quarterly Sales Dip

Bayer reports major progress with Monsanto acquisition.

Latest News


Valagro Launches Fertilizer Line in China

Valagro, an Italian supplier of biostimulants and other specialty nutrients, said it launched its water-soluble fertilizers, Master Supreme, to the Chinese market.


As Agchem Complexity Grows, Specialists Take Off Some of the Heat

Chemical companies increasingly are using specialist suppliers to outsource the process development and production of complex new molecules.

Precision Ag

Indigo Touts ‘New Approach to Agricultural R&D’

Indigo Research Partners uses a network of more than 50 of the largest U.S. growers to gather over a trillion data points daily from sensors, drones, weather stations, and other technologies.


Scientists Introduce Simpler, Faster CRISPR

Gene editing just got easier, thanks to an international team of researchers.


FaunaSmart, BioScience Solutions Form Innovative Collaboration in Crop Protection

FaunaSmart and BioScience Solutions have announced a cooperation within strategic business development and innovation strategies in crop protection. Harry Teicher,